Hettmann, Thore,Freeman, Daniel J.,Radinsky, Robert
申请号：
AU2015201263
公开号：
AU2015201263B2
申请日:
2015.03.11
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
#$%^&*AU2015201263B220170112.pdf#####ABSTRACT Described herein are materials and methods for treating subjects having a HER-3 associated disease, by administering a first agent that binds to HER-3, in combination with a second agent that binds and/or inhibits another member of the HER family. The first and the second agent may be a biologic, such as an antigenbinding protein, or a small molecular tyrosine kinase inhibitor, for example.
